Assessment of BMS284756 MIC and 5-μg disk diffusion quality control studies tested against seven American type culture collection strains

被引:3
作者
Biedenbach, DJ
Jones, RN
机构
[1] Jones Grp, JMI Labs, Beaver Kreek Ctr 345, N Liberty, IA 52317 USA
[2] Tufts Univ, Sch Med, Boston, MA 02111 USA
关键词
D O I
10.1016/S0732-8893(01)00294-2
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
BMS284756 is a novel des-fluoro(6)-quinolone with antimicrobial activity similar to recently developed fluorinated quinolones. The purpose of this investigation was to determine the appropriate disk diffusion and MIC quality control (QC ranges for BMS284756 when used against commonly tested QC strains (M23-A2). The BMS284756 5-mug disk content was tested against Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853, Hemophilus influenzae ATCC 49247, Streptococcus pneumoniae ATCC 49619 and Staphylococcus aureus ATCC 25923. In addition, Enterococcus faecalis ATCC 29212 and S. aureus ATCC 29213 were evaluated by the broth microdilution method. Seven laboratories tested 2 disk lots on 3 agar media or 3-4 broth lots over a 10 day period. A total of 420 zone diameter values and 210 or 280 MIC values per organism were generated. The following disk diffusion and MIC QC ranges were suggested for BMS284756 and the seven QC strains: E. coli ATCC 25922 (28-35 mm/0.004-0.016 mug/mL), E. faecalis ATCC 29212 (0.03-0.25 mug/mL), S. aureus ATCC 25923 (30-36 mm), S. aureus ATCC 29213 (0.004-0.016 mug/mL), P. aeruginosa ATCC 27853 (19-25 mm/0.5-2 mug/mL), H. Influenzae, ATCC 49247 (33-41 mm/0.002-0.008mug/mL), S. pneumoniae ATCC (26-33 mm/0.016-0.06 mug/mL). The proportion of participant results observed within the proposed ranges was 97.4-98.8% and 94.6-100% for the disk diffusion and MIC tests, respectively. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:225 / 228
页数:4
相关论文
共 12 条
[1]  
DESHPANDE L, 2001, IN PRESS INTERN J AN
[2]   Antibacterial spectrum of a novel des-fluoro(6) quinolone, BMS-284756 [J].
Fung-Tomc, JC ;
Minassian, B ;
Kolek, B ;
Huczko, E ;
Aleksunes, L ;
Stickle, T ;
Washo, T ;
Gradelski, E ;
Valera, L ;
Bonner, DP .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (12) :3351-3356
[3]   Activities of BMS 284756 (T-3811) against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae isolates from SENTRY Antimicrobial Surveillance Program Medical Centers in Latin America (1999) [J].
Gales, A ;
Sader, H ;
Jones, RN .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (05) :1463-1466
[4]  
HAYASHI K, 1997, 37 INT C ANT AG CHEM, P173
[5]   Comparative antianaerobic activity of BMS 284756 [J].
Hoellman, DB ;
Kelly, LM ;
Jacobs, MR ;
Appelbaum, PC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (02) :589-592
[6]  
NAGAI A, 1997, 37 INT C ANT AG CHEM, P173
[7]  
*NAT COMM CLIN LAB, 2000, M7A7 NCCLS
[8]  
*NAT COMM CLIN LAB, 2001, M23A2 NCCLS
[9]  
National Committee for Clinical Laboratory Standards, 2000, M7A5 NCCLS
[10]   Activity of BMS284756 (T-3811) tested against anaerobic bacteria, Campylobacter jejuni, Helicobacter pylori and Legionella spp. [J].
Rhomberg, PR ;
Biedenbach, DJ ;
Jones, RN .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2001, 40 (1-2) :45-49